MERUS N V's ticker is MRUS and the CUSIP is N5749R100. A total of 44 filers reported holding MERUS N V in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,221,999 | +30.4% | 179,050 | +45.6% | 0.00% | – |
| Q2 2023 | $3,238,774 | +44.6% | 123,007 | +1.1% | 0.00% | – |
| Q1 2023 | $2,239,758 | +18.9% | 121,726 | 0.0% | 0.00% | – |
| Q4 2022 | $1,883,101 | -25.6% | 121,726 | -3.6% | 0.00% | – |
| Q3 2022 | $2,530,000 | +0.9% | 126,266 | +14.0% | 0.00% | – |
| Q2 2022 | $2,507,000 | -21.6% | 110,716 | -8.4% | 0.00% | – |
| Q1 2022 | $3,196,000 | -16.4% | 120,889 | +0.5% | 0.00% | – |
| Q4 2021 | $3,824,000 | +37.5% | 120,251 | -4.9% | 0.00% | – |
| Q3 2021 | $2,782,000 | +19.0% | 126,436 | +14.0% | 0.00% | – |
| Q2 2021 | $2,338,000 | +38.6% | 110,932 | +37.4% | 0.00% | – |
| Q1 2021 | $1,687,000 | +74.1% | 80,732 | +46.1% | 0.00% | – |
| Q4 2020 | $969,000 | +50.5% | 55,254 | +2.8% | 0.00% | – |
| Q3 2020 | $644,000 | -28.7% | 53,741 | -4.3% | 0.00% | – |
| Q2 2020 | $903,000 | – | 56,150 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lynx1 Capital Management LP | 1,150,225 | $27,122,306 | 17.94% |
| COMMODORE CAPITAL LP | 4,428,072 | $104,413,938 | 12.20% |
| Medicxi Ventures Management (Jersey) Ltd | 1,600,000 | $37,728,000 | 12.04% |
| Aquilo Capital Management, LLC | 430,109 | $10,141,970 | 9.19% |
| Ally Bridge Group (NY) LLC | 221,384 | $5,220,235 | 6.13% |
| Fairmount Funds Management LLC | 1,881,345 | $44,362,115 | 5.34% |
| VR Adviser, LLC | 1,726,214 | $40,704,126 | 4.28% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 500,000 | $11,790,000 | 3.58% |
| DAFNA Capital Management LLC | 484,870 | $11,433,235 | 3.56% |
| Nan Fung Group Holdings Ltd | 137,038 | $3,231,356 | 2.62% |